Finance Home - My Yahoo - Yahoo! - Help

Friday, January 8, 2010, 3:09PM ET - U.S. Markets close in 51 mins.. Dow  0.24% Nasdaq  0.55%

Forest Laboratories Inc. (FRX)

At 2:54PM ET: 30.87   0.50 (1.59%)

MORE ON FRX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Oct 20, 2009 • Outlook roundup: Sherwin-Williams, Crown Castle AP (Tue, Oct 20) • Biotech Stocks: Drug stocks follow broader market lower at MarketWatch (Tue, Oct 20) • Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst Wall Street Transcript (Tue, Oct 20) • Forest Labs trims 2010 outlook on higher R&D costs AP (Tue, Oct 20) • Forest Laboratories, Inc. Earnings Call scheduled for 10:00 am ET today CCBN (Tue, Oct 20) • Forest Labs 2Q profit slides on drug costs AP (Tue, Oct 20) • Forest reports lower profit due to charges at MarketWatch (Tue, Oct 20) • Forest Laboratories, Inc. Reports Fiscal Second Quarter 2010 Earnings Per Share of $0.61, Including a Net $0.24 Per Share Charge for One-Time Items Business Wire (Tue, Oct 20) • AKT Inhibitor Moving Into Phase III Trials: Ladenburg Thalmann Sees This As Catalyst For Investors Wall Street Transcript (Tue, Oct 20) • Q2 2010 Forest Laboratories, Inc. Earnings Release - Before Market Open CCBN (Tue, Oct 20) Mon, Oct 19, 2009 • Forest, Cypress say Savella met goal in study AP (Mon, Oct 19) Sat, Oct 17, 2009 • Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experience Improvements in Pain and Physical Function Business Wire (Sat, Oct 17) Fri, Oct 16, 2009 • Targacept Unveils Stellar Depression Drug Data: BioBuzz at TheStreet.com (Fri, Oct 16) Thu, Oct 15, 2009 • Weak Dollar And Low Valuation To Boost J&J at Investopedia (Thu, Oct 15) Wed, Oct 14, 2009 • 5-Star Stocks on the Upswing at Motley Fool (Wed, Oct 14) Fri, Sep 25, 2009 • New Drugs, India-Style at Forbes.com (Fri, Sep 25) Thu, Sep 24, 2009 • Beacon Equity Issues Technical Trading Overview for Discovery Laboratories Inc. GlobeNewswire (Thu, Sep 24) Tue, Sep 22, 2009 • These Pros Aren't Scared of Obamacare. Why Are You? at Motley Fool (Tue, Sep 22) • [$$] Don't Rely on Relative Valuation at RealMoney by TheStreet.com (Tue, Sep 22) Thu, Sep 17, 2009 • Spending Now Gives Companies an Edge Later RealMoney by TheStreet.com (Thu, Sep 17) Fri, Aug 28, 2009 • Conference Call to Review Publication of Daxas Ph. III Clinical Trial Results scheduled for 7:15 am ET today CCBN (Fri, Aug 28) Mon, Aug 24, 2009 • Get Briefed: Bruce Berkowitz at Forbes.com (Mon, Aug 24) • Transcript: Bruce Berkowitz at Forbes.com (Mon, Aug 24) Fri, Aug 21, 2009 • Berkowitz Beats S&P at Forbes.com (Fri, Aug 21) Wed, Aug 19, 2009 • Three Sectors for the Downturn at TheStreet.com (Wed, Aug 19) Older Headlines - Most Recent Headlines View headlines from: Wed, Aug 19, 2009Wed, Aug 12, 2009Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009Wed, Jul 1, 2009Wed, Jun 24, 2009Wed, Jun 17, 2009 Add FRX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage